|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 48/00 | |
| C12N 15/64 | |||
| C12N 5/10 |
| (11) | Patento numeris | 3110454 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 15752803.5 |
| Europos patento paraiškos padavimo data | 2015-02-24 | |
| (97) | Europos patento paraiškos paskelbimo data | 2017-01-04 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-11-18 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2015/017302 |
| Data | 2015-02-24 |
| (87) | Numeris | WO 2015/127439 |
| Data | 2015-08-27 |
| (30) | Numeris | Data | Šalis |
| 201461943865 P | 2014-02-24 | US |
| (72) |
HOLMES, Michael C., US
WECHSLER, Thomas, US
|
| (73) |
Sangamo Therapeutics, Inc.,
501 Canal Blvd. Suite A100, Richmond, CA 94804,
US
|
| (54) | METHODS AND COMPOSITIONS FOR NUCLEASE-MEDIATED TARGETED INTEGRATION |
| METHODS AND COMPOSITIONS FOR NUCLEASE-MEDIATED TARGETED INTEGRATION |